High throughput screens for the identification of compounds that alter the accumulation of the Alzheimer's amyloid β peptide (Aβ)

Journal of Neuroscience Methods

Volumn 108, Issue 2, 2001, Pages 171-179

  Haugabook, S J ^a   Yager, D M ^a   Eckman, E A ^a   Golde, T E ^a   Younkin, S G ^a   Eckman, C B ^a  

^a MAYO CLINIC   (United States)

Author keywords

Alzheimer's disease; Amyloid; Beta amyloid accumulation, A ; Cell; Drug screen; High throughput screen (HTS); In vitro

Indexed keywords

AMMONIUM CHLORIDE; AMYLOID BETA PROTEIN; CAFFEINE; CHLOROQUINE; PHORBOL DIBUTYRATE; WORTMANNIN;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL LINE; CELL SUSPENSION; CHO CELL; CONTROLLED STUDY; DRUG SCREENING; ENZYME LINKED IMMUNOSORBENT ASSAY; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; BIOLOGICAL ASSAY; CELL CULTURE TECHNIQUES; CELL SURVIVAL; CELLS, CULTURED; CHO CELLS; CRICETINAE; CULTURE MEDIA, CONDITIONED; DRUG EVALUATION, PRECLINICAL; DRUG TOXICITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS; REPRODUCIBILITY OF RESULTS; TOXICITY TESTS;

EID: 0035974232     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0270(01)00388-0     Document Type: Article

References (28)

1. Inflammation and Alzheimer's disease
2. Protein phosphorylation inhibits production of Alzheimer amyloid β/A4 peptide
3. Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain
4. The role of cholesterol in the biosynthesis of β-amyloid
5. Neurohormonal signaling pathways and the regulation of Alzheimer β-amyloid precursor metabolism
6. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein
7. Biochemical detection of Aβ isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease
8. Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide
9. Normal cellular processing of the β-amyloid precursor protein results in the secretion of the amyloid beta peptide and related molecules
10. Activation of protein kinase C inhibits cellular production of the amyloid β-protein
11. The toxicity in vitro of β-amyloid protein
12. The release of Alzheimer's disease β amyloid peptide is reduced by phorbol treatment
13. Seeding 'one-dimensional crystallization' of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?
14. The C-terminus of the β protein is critical in amyloidogenesis
15. The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease
16. Phorbol esters affect multiple steps in β-amyloid precursor protein trafficking and amyloid β-protein production
17. The secretion of amyloid β-peptides is inhibited in the tacrine-treated human neuroblastoma cells
18. Amyloid plaque core protein in Alzheimer disease and Down syndrome
19. Presenilin 1 regulates pharmacologically distinct γ-secretase activities. Implications for the role of presenilin in γ-secretase cleavage
20. The phosphatidylinositol 3-kinase inhibitor wortmannin alters the metabolism of the Alzheimer's amyloid precursor protein
21. Calcium ionophore increases amyloid β peptide production by cultured cells
22. Caffeine stimulates amyloid β-peptide release from β-amyloid precursor protein-transfected HEK293 cells
23. Glycosylphosphatidylinositol-anchored proteins play an important role in the biogenesis of the Alzheimer's amyloid β-protein
24. Production of the Alzheimer amyloid β protein by normal proteolytic processing
25. An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (βAPP717) mutants
26. Mechanisms of neuronal degeneration in Alzheimer's disease